Buy ADB-B / ADB-BUTINACA Powder – Premium Research Chemical | euro-labchems.com

Buy ADB-B / ADB-BUTINACA Powder (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide) CAS Number: 1185882-07-6 (freebase reference) Molecular Formula: C₁₈H₂₆N₄O₂ Molecular Weight: 330.43 g/mol Purity: ≥98.5% (HPLC verified) Appearance: White to off-white fine crystalline powder Form: Freebase or hydrochloride salt – stable, soluble Quantity options: 1 g, 5 g, 10 g, 25 g, 50 g+ Shipping: Discreet worldwide, vacuum-sealed packaging

euro-labchems.com supplies laboratory-grade ADB-B / ADB-BUTINACA – a synthetic cannabinoid of the indazole-3-carboxamide class, structurally related to ADB-FUBINACA and MDMB-BUTINACA. First identified in forensic samples around 2019–2020, ADB-BUTINACA is one of the most potent synthetic cannabinoids currently monitored, acting as a full agonist at CB₁ and CB₂ cannabinoid receptors.

What is ADB-B / ADB-BUTINACA?

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide) is a designer cannabinoid developed to mimic the effects of natural THC but with significantly higher potency and affinity for cannabinoid receptors. It supports advanced pharmacological, receptor-binding, metabolic, and toxicological research on synthetic cannabinoid receptor agonists (SCRAs).

Key Product Specifications

• Purity: ≥98.5% (third-party HPLC)
• Form: Fine, free-flowing crystalline powder
• Solubility: Good in ethanol, DMSO; moderate in water (HCl form improves)
• Stability: Excellent cool/dark/dry storage (2+ years)
• Full CoA available on request

Research Effects & Characteristics

Duration: Variable (research observations suggest 2–6 hours) Onset: 5–30 minutes (route-dependent models)

Preclinical and forensic literature indicate extremely potent cannabinoid effects: intense CB₁-mediated responses including sedation, analgesia, catalepsy, hypothermia, hypolocomotion, and profound psychoactive alterations. Frequently described as one of the most potent SCRAs, with effects occurring at microgram doses and high risk of severe intoxication in non-controlled settings.

Possible side effects (dose-dependent, research observations): tachycardia, hypertension, agitation, psychosis-like states, seizures, respiratory depression, acute kidney injury, hyperthermia, cardiovascular collapse, potential for rapid tolerance and dependence.

ADB-B / ADB-BUTINACA powder is sold strictly for scientific research – not for human/veterinary consumption. Verify local regulations.

Premium ADB-BUTINACA powder for precise cannabinoid receptor research from euro-labchems.com – your trusted specialist.